The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy
|
|
- Gillian Cox
- 5 years ago
- Views:
Transcription
1 The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy
2 Introduction Colposcopic impression alone has been shown to be subjective with variable rates of sensitivity and specificity for the detection of high grade CIN lesions; 32 92% 1. This may lead to subjecting a woman to unnecessary interventions. failure to identify high grade changes putting women at risk of development of cervical cancer in the future. 1. Ferris DG, for the ATLS group. Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS. Am J Obstet Gynecol 2006;194:704 10
3 ZedScan ZedScan is a handheld device that uses electrical impedance spectroscopy to differentiate between tissues. It has been shown to improve colposcopic performance by aiding the detection of high grade CIN 2 without increasing biopsies rates Tidy JA, Brown BH, Healey TJ, Daayana, Martin SM, Prendiville W, Kitchener HC. Accuracy of detection of high grade cervical intraepithelial neoplasia using electrical impedance spectroscopy with colposcopy. BJOG: An International Journal of Obstetrics & Gynaecology 2013;120(4): Tidy JA, Brown B, Healey J, Lyon R, Palmer J. ZedScan (Electrical impedance spectroscopy) with colposcopy increases the detection of HG-CIN in women referred with low grade cytology. Poster Presentation BSCCP ASM th April 2015
4 ZedScan
5 Aims and Objectives of the Service Review To evaluate the routine use of the ZedScan as an adjunct to colposcopy within our clinic, in particular the ability to identify high grade CIN. ZedScan has been used routinely within the colposcopy clinic in Sheffield by two consultants and three nurse colposcopists since December 2013.
6 Method Women referred to the Sheffield Colposcopy Clinic from 1st December 2013 to 30th September The Colposcopy Clinic and ZedScan databases were used to identify women. Baseline statistical analysis was performed using Microsoft Excel TM.
7 Results 499 women underwent colposcopy with ZedScan during the time period. 2 women were referred with normal smears but abnormal appearance of the cervix. 34 women were excluded from the analysis leaving a study group of 465. Reasons for exclusion; failed quality assurance of the ZedScan device (21), incomplete dataset (12) and one women was pregnant. 90% were examined by nurse colposcopists. 439 (94%) of women were referred with abnormal screening cytology, 29% had moderate or severe dyskaryosis. Screening sample result No. of patients (%) High risk (HR) HPV only 9 (2) Borderline 166 (38) Mild dyskaryosis 129 (29) Moderate dyskaryosis 51 (12) Severe dyskaryosis 75 (17) Glandular 9 (2)
8 Results overall biopsy rate 292 women (63%) had a biopsy (diagnostic or excision at their first visit). National rate for biopsy in colposcopy for 2012/ %
9 Women with high grade cytology (82%) had a colposcopic impression of high grade disease 117 (89%) had a positive ZedScan result 7 had low grade disease on colposcopic impression 12 had a normal colposcopic impression; 3 of these had no biopsy (all moderate dyskaryosis and negative ZedScan results); 2 were atrophic, 1 had HPV changes and the other 6 had normal histology on biopsy 73 women (58%) had CIN 3 on biopsy and 18 (14%) had CIN 2 3 women were found to have invasive cancer on histology 61 (48%) had See and Treat at first visit, 100% had high grade disease including 3 with invasive cancer.
10 ZedScan as an adjunct to colposcopy ZedScan and colposcopy opinion regarding the need for biopsy were in agreement in 82% of cases. Both colposcopy and ZedScan were normal in 151 women allowing them to be discharged to routine recall at their first clinic visit. Colposcopic opinion and ZedScan both found abnormalities requiring biopsy in 228 cases. Statistical analysis shows substantial agreement, Kappa = 0.67 (95%CI )
11 Agreement between colposcopic impression of high grade disease and positive ZedScan result 180 women (39%) had a colposcopic impression of high grade disease Of these 172 (96%) had a positive ZedScan result
12 When ZedScan and colposcopic impression differed 285 (61%) women had a colposcopic impression which was normal, HPV changes only, metaplasia, atrophic changes or low grade disease 171 (60%) had a negative ZedScan result, 21 went onto have a punch biopsy - 13 had normal histology or HPV only - 7 had CIN 1-1 had CIN (40%) were ZedScan positive for high grade disease, 92 went onto have a punch biopsy - 55 had normal histology or HPV only - 21 had CIN 1-16 (14%) had high grade histology; 10 CIN2, 4 CIN 3, 1 ungradeable CIN and 1 adenocarcinoma insitu
13 When ZedScan and colposcopic impression differed In 179 women ZedScan did not recommend a biopsy, of these 29 went onto have a biopsy; 8 had a colposcopic impression of high grade disease. Histology Normal or HPV / inflammation only No. of women CIN 1 9 CIN 2 2 CIN 3 1 CGIN 1 16 Overall 4 cases of high grade disease were identified, 2 % of all women with a negative ZedScan result. Colposcopic impression missed 16 cases on high grade disease, 6% of all women with a negative colposcopic impression.
14 See and Treat with ZedScan 62 women (13%) had See and Treat with LLETZ Of these 61 were referred with high grade cytology All histology was high grade disease Rate of See and Treat for women referred with high grade cytology was 48%, higher than the rates for 3 previous years; 36 39%
15 Conclusions ZedScan has been used routinely in our colposcopy clinic since December The colposcopist can be confident in discharging women or performing an excisional biopsy ( See and Treat ) at the first visit when both colposcopic impression and ZedScan is agree. An additional 16 cases (14%) of high grade disease were identified by ZedScan where colposcopic impression was normal or low grade disease. Only 3% of all high grade histology was not identified by ZedScan whereas colposcopy failed to identify 11% of all high grade histology. The See and Treat rate since ZedScan has been introduced has increased from previous years and 100% of cases had high grade disease.
ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust
ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection
More informationZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust
ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection
More informationPlus ça change. CWE Redman Colposcopy Symposium, ECC 2016
Plus ça change. CWE Redman Colposcopy Symposium, ECC 2016 UHNM What we know HPV primary screening coming More sensitive: more HSIL detected Increase in workload Longer consultations More anxiety HPV Primary
More informationa new standard in colposcopy
a new standard in colposcopy Seamless integration into colposcopic practice Non-visual diagnosis Rapid real-time results Improved accuracy Better patient management Simple, easy to use system an objective
More informationScottish Cervical Screening Programme. Colposcopy and Programme Management
Scottish Cervical Screening Programme Colposcopy and Programme Management Addendum to NHSCSP Publication No 20 Second Edition Exceptions Applicable in NHS Scotland April 2013 (Final Version 2.8 to incorporate
More informationpat hways Medtech innovation briefing Published: 12 February 2015 nice.org.uk/guidance/mib20
pat hways The ZedScan as an adjunct to colposcopy in women with suspected cervical intra-epithelial neoplasia Medtech innovation briefing Published: 12 February 2015 nice.org.uk/guidance/mib20 Summary
More informationThe implications of HPV immunisation on cervical screening
The implications of HPV immunisation on cervical screening Dr Maggie Cruickshank Senior Lecturer in Gynaecology Scottish Cervical Cancer Prevention Programme (SCCPP) funded by CSO Cervical screening Detects
More informationName of External Assessment Group (EAG) and project leads
Title of the project Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: a systematic review and economic evaluation Name of External Assessment Group (EAG) and project leads
More informationEfficacy of cervical intrarepithelial neoplasia (CIN)
The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,
More informationcle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22
BJMP 2008:1(2) 18-22 Review Articl cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil Abbreviations BSCCP British Society of Colposcopy and Cervical Pathology CIN Cervical intraepithelial
More informationCytology Update M Laing QEUH
Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME
More informationDiagnostics guidance Published: 25 April 2018 nice.org.uk/guidance/dg32
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I Diagnostics guidance Published: 25 April 2018 nice.org.uk/guidance/dg32
More informationOver-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
More informationSMALL DESIGN SMART INNOVATION
SMALL DESIGN SMART INNOVATION The new Touch and Ultra Changing the Face of Colposcopy Significant improvements have changed the cervical cancer screening pathway over the last 20 years, resulting in high
More informationAcceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index
DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila
More informationHow invasive cervical cancer audit affects clinical practice
How invasive cervical cancer audit affects clinical practice Referring to NHSCSP and EU guidelines and audits in Southampton and London Amanda Herbert Guy s & St Thomas Foundation NHS Trust How invasive
More informationAdjunctive colposcopy technologies for examination of the uterine cervix DySIS, LuViva Advanced Cervical Scan and Niris Imaging System
Appendix 9 Further LuViva analysis Following several requests for clarification and extra information Guided Therapeutics provided two tables on the accuracy of LuViva and colposcopy (personal correspondence
More informationLLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation
LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation Bridget Melley BSc. (Hons.) in Medical Science Galway-Mayo Institute
More informationTHEME: Changes in the care pathway. Changes to the Cervical Screening Pathway
Diagnostics Consultation Document s received during consultation from August to September 2017 THEME: Changes in the care pathway 1 DYSIS Medical Limited 2 2.4 2.10 5 5.2 Changes to the Cervical Screening
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationThe role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial
DOI: 10.1111/j.1471-0528.2010.02519.x www.bjog.org Epidemiology The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial
More information6 th EFC Satellite meeting, Saturday 1 st December 2018
6 th EFC Satellite meeting, Saturday 1 st December 2018 Introduction Pekka Nieminen President-elect of the European Federation for Colposcopy, Department of Obstetrics and Gynaecology, Helsinki University
More informationCryotherapy has No Place in Colposcopy Practice
Cryotherapy has No Place in Colposcopy Practice No financial disclosures No conflicts of interest ? Precision? Personalized Medicine? Best Evidence Based Practice Prinicipals of Surgical Management CIN1
More informationCERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02
CERVICAL SCREENING WALES INFORMATION TEAM STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2001/02 For more information about this report contact: Helen Beer, Information Analyst / Manager, Screening
More informationGUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) Approved by Guidelines Assessment Panel
NORFOLK & WAVENEY CELLULAR PATHOLOGY SERVICE GUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) DEPT. SOP NO.:C.SC.I.806b EDITION: 8 AUTHORISED BY: See table below AUTHOR: VIKI FREW DATE OF ISSUE:
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 8 No ISSN 75 876 Findings and outcome of teenage women referred for colposcopy at Christchurch Women s Hospital, New Zealand Peter Sykes, Dianne Harker, David Peddie
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationCuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015
Programme Report 2014/2015 Contents Summary points 2 Introduction to the statistics 2014/2015 3 Part 1 Cervical screening activity 3 Programme coverage 4 Laboratory turnaround time 7 Notification of results
More informationAbnormal Smear (Cytology) Results What do they mean?
Abnormal Smear (Cytology) Results What do they mean? Obstetrics & Gynaecology Women & Children s Services This leaflet has been designed to give you important information about your condition / procedure,
More informationEFC and European Standards for Colposcopic Evaluation
EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic
More informationEffect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years
DOI: 10.1111/j.1471-0528.2008.01853.x www.blackwellpublishing.com/bjog Gynaecological oncology Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50
More informationA clinical review of borderline glandular cells reported on liquid-based cervical cytology
DOI: 10.1111/j.1471-0528.2009.02477.x www.bjog.org Gynaecological oncology A clinical review of borderline glandular cells reported on liquid-based cervical cytology A Patel, a N Thampy, b D Hemming, b
More informationA comparative study of two methods of large loop excision of the transformation zone
BJOG: an International Journal of Obstetrics and Gynaecology April 2005, Vol. 112, pp. 490 494 DOI: 10.1111/j.1471-0528.2005.00427.x A comparative study of two methods of large loop excision of the transformation
More informationTreatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?
Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this
More informationManagement Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
More informationOriginal Policy Date
MP 2.04.03 Cervicography Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index Disclaimer
More informationGlandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 5 Number 2 Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen,
More informationTo further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy
1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous
More informationGynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c
DOI: 10.1111/1471-0528.13200 www.bjog.org Gynaecological surgery Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled
More informationKC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales
KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales CERVICAL SCREENING WALES STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2012/2013 For more information
More informationCervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital
Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before
More informationQuantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease
Quantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease Nahida Chakhtoura, MD, Leo Twiggs, MD, Timothy DeSantis, MD Claudia Werner, MD, William
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationNorthern Ireland cervical screening programme. Information for primary care and smear takers
Northern Ireland cervical screening programme Information for primary care and smear takers From January 2011, the Northern Ireland cervical screening programme will no longer invite women aged under 25
More informationRisk of invasive cancer after colposcopy with and without biopsy
Risk of invasive cancer after colposcopy with and without biopsy Guglielmo Ronco MD Senior Epidemiologist Adele Caprioglio MSc, Giovanni Maina MD Colposcopist, Mario Preti MD Colposcopist City of Health
More informationWIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS
Author J. Evans BMS 3 Authoriser A. Bamber Page 1 of 16 WIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS Author J. Evans BMS 3 Authoriser
More informationInvestigation of 100 consecutive negative cone biopsies
British Journal of Obstetrics and Gynaecology January 1997, Vol. 104, pp. 100-104 Investigation of 100 consecutive negative cone biopsies *Pouran Golbang Research Fellow and Consultant (Gynaecology), **James
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationCompleteness of excision and follow up cytology in patients treated with loop excision biopsy
J Clin Pathol ;:9 9 9 Department of Pathology, Mayday University Hospital, London Road, Thornton Heath, Surrey CR7 7YE, UK A M Zaitoun M J Coppen S M Thomas Department of Pathology, The Royal Surrey County
More informationWoo Dae Kang, Ho Sun Choi, Seok Mo Kim
Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam
More informationBecoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
More informationPartha Basu M.D. Screening Group/ Early Detection & Prevention Section
Current Status of Quality Assured Colposcopy Practice in South Asia Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Disclosures No financial disclosure NO conflict of interest to
More informationCERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix
More informationWhat is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester
What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester Qu. What is being excised? A. Colposcopic lesions which should contain CIN2+ Qu. Why is
More informationABSTRACT 1. INTRODUCTION. Tajossadat Allameh 1, Somayeh Khanjani 2, Fereshteh Mohammadizadeh 3*, Elaheh Refaei 4. sions.
Open Journal of Obstetrics and Gynecology, 213, 3, 341-346 http://dx.doi.org/.4236/ojog.213.363 Published Online May 213 (http://www.scirp.org/journal/ojog/) OJOG Diagnostic of the combination of TruScreen
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationManagement that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More informationCytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationORIGINAL ARTICLES. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. Methods
Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town Priya Batra, Louise Kuhn, Lynette Denny Objective. An audit of outcomes of cervical cancer screening
More informationTelemedicine enables doctors in rural areas. Remote diagnosis of cervical neoplasia: 2 types of telecolposcopy compared with cervicography
Brief Report Remote diagnosis of cervical neoplasia: 2 types of telecolposcopy compared with cervicography Daron G. Ferris, MD, Mark S. Litaker, PhD, Michael S. Macfee, MD, and Jill A. Miller, MD Medical
More informationInformation on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationNorthern Ireland Cervical Screening Programme
Northern Ireland Cervical Screening Programme ANNUAL REPORT & STATISTICAL BULLETIN 2010-2011 1 Report produced by : Quality Assurance Reference Centre, PHA Date of Publication: September 2012 2 Contents
More informationInformation on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationThe Role of The Advanced Practitioner in Cytology
The Role of The Advanced Practitioner in Cytology Margaret Morgan Head of Service Cellular Pathology GSTS Pathology London Odense, Denmark 5 th March 2011 St Thomas Hospital London County Down Overview
More informationReduction in colposcopy workload and associated clinical activity following HPV catch-up vaccination
1 2 Reduction in colposcopy workload and associated clinical activity following HPV catch-up vaccination programme in Scotland: an ecological study 3 4 5 Cruickshank M E 1, Pan J 4, Cotton SC 1, Kavanagh
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationImmediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review)
Cochrane Database of Systematic Reviews Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test Kyrgiou M, Kalliala IEJ,
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationMolecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus
University of Groningen Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationHKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists
HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of
More informationRunning head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY
Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of
More informationNational Surveillance System for Human Papillomavirus Infection and Related Disease in Scotland
National Surveillance System for Human Papillomavirus Infection and Related Disease in Scotland Version Date: 10th October 2008 Proposal prepared by: M O Leary (EPIET), C. Robertson (Statistics), K. Sinka
More informationProposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT
Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT National Cervical Screening Programme National Screening Unit Ministry of Health October 2006 Table of
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationColposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic
Colposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic Gregory L. Brotzman, MD; Kenneth G. Schellhase, MD, MPH ABSTRACT Purpose: We sought to assess colposcopic proficiency
More informationAbnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia
Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia Leo B. Twiggs, M.D. Professor Emeritus University of Miami Miller School of Medicine Miami Florida USA Currently- Women
More informationA clinical review of borderline glandular cells on cervical cytology
British Journal of Obstetrics and Gynaecology May 2000, Vol07, pp. 605-609 A clinical review of borderline glandular cells on cervical cytology D. Kusnah A. Mohammed Research Senior House Oflcer, Ofer
More informationReduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy
ACTA BIOMED 2007; 78: 36-40 Mattioli 1885 O R I G I N A L A R T I C L E Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy
More informationThe multidisciplinary colposcopy meeting: recommendations for future service provision and an analysis of clinical decision making
DOI: 10.1111/j.1471-0528.2010.02651.x www.bjog.org Gynaecological oncology The multidisciplinary colposcopy meeting: recommendations for future service provision and an analysis of clinical decision making
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationFluorescence Spectroscopy and Imaging for Photodetection of Cervical Intraepithelial Neoplasia
Imaging for Photodetection of Cervical Intraepithelial Neoplasia Thomas Stepinac 1, Attila Major 2, Frank Lüdicke 2, Didier Goujon 1, Nora Dögnitz 1, Tanja Gabrecht 1, Norbert Lange 1, Hubert van den Bergh
More informationAssociate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.
Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor
More informationCOLPOSCOPY QUALITY IMPROVEMENT PROGRAM (C QuIP) VICTORIAN CERVICAL CYTOLOGY REGISTRY PILOT STUDY. Dorota Gertig, Marion Saville
COLPOSCOPY QUALITY IMPROVEMENT PROGRAM (C QuIP) VICTORIAN CERVICAL CYTOLOGY REGISTRY PILOT STUDY Dorota Gertig, Marion Saville on behalf of the C QuIP Steering Committee June 2013 1 CONTENTS 1. Executive
More informationGYNAECOLOGICAL CYTOLOGY
The laboratory runs a tour of the department for Practice Nurses on request, as part of their training, explaining the procedures and requirements for Gynae LBC. RECOMMENDED PROTOCOL FOR SMEAR TAKERS Only
More informationPatients referred to a colposcopy clinic will often have
The Accuracy of the Papanicolaou Smear in the Screening and Diagnostic Settings Marylou Cárdenas-Turanzas, MD, DrPH, 1 Michele Follen, MD, PhD, 2 Graciela M. Nogueras-Gonzalez, MPH, 1 J.L. Benedet, MD,
More informationYou have been asked to come for a Colposcopy examination because your cervical screening test (smear) has shown evidence of abnormal cells.
Colposcopy Examination One Stops Patient Information Sheet Why do I need a Colposcopy examination at the one stop clinic? You have been asked to come for a Colposcopy examination because your cervical
More informationThe comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting
BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1542 1546 DOI: 10.1111/j.1471-0528.2005.00699.x The comparative diagnostic accuracy of conventional and liquid-based
More informationBiomed Environ Sci, 2015; 28(1): 80-84
80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG
More informationComparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer
BJOG: an International Journal of Obstetrics and Gynaecology August 2004, Vol. 111, pp. 842 848 DOI: 1 0. 1111/j.1471-0528.2004.00210.x Comparison of HPV test versus conventional and automation-assisted
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationREVIEW OF SCREENING RECOMMENDATIONS FROM AROUND THE WORLD: Perspective of the IFCPC
REVIEW OF SCREENING RECOMMENDATIONS FROM AROUND THE WORLD: Perspective of the IFCPC (International Federation for Cervical Pathology and Colposcopy) Walter Prendiville, MD IFCPC President Disclosure of
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationRESPONSE TO DECISION LETTER
RESPONSE TO DECISION LETTER Dear Editor-in-chief, We are grateful to the editors and reviewers for their time and constructive comments on our manuscript. We have implemented their comments and suggestions
More informationManagament of Abnormal Cervical Cytology and Histology
Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationComparison of an optoelectronic scan of the cervix, cervical cytology and HPV genotyping for CIN screening
Comparison of an optoelectronic scan of the cervix, cervical cytology and HPV genotyping for CIN screening Ricardo Lúa Alvarado President of Occident Colposcopy and Genital Pathology College Professor
More information